Meeting
2015 ASCO Annual Meeting
Intra-patient genomic heterogeneity of single circulating tumor cells (CTCs) associated to phenotypic CTC heterogeneity in metastatic castrate resistant prostate cancer (mCRPC).
Authors
Mark Landers
Epic Sciences, Inc., San Diego, CA
Mark Landers , Stephanie Greene , Nicole A. Schreiber , Angel Rodriguez , Richard Martin Bambury , Daniel Costin Danila , Dana E. Rathkopf , Martin Fleisher , Jessica Louw , Adam Jendrisak , Dena Marrinucci , Ryan Vance Dittamore , Howard I. Scher
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Circulating Tumor Cells
Citation
J Clin Oncol 33, 2015 (suppl; abstr 11035)
DOI
10.1200/jco.2015.33.15_suppl.11035
Abstract #
11035
Poster Bd #
247
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of a prostate cancer gastrointestinal transcriptional phenotype as found in clinical mCRPC samples with response to AR-targeted therapy.
First Author: Aishwarya Subramanian
Poster
2024 ASCO Genitourinary Cancers Symposium
Chromatin modifications on plasma ctDNA as a tool to phenotype castration-resistant prostate cancer.
First Author: Asli Munzur
Poster
2023 ASCO Genitourinary Cancers Symposium
Effect of Janus kinase (JAK) signaling inhibition on lineage plasticity and drug sensitivity in castrate resistant prostate cancer.
First Author: Samir Zaidi
Poster
2021 ASCO Annual Meeting
Complementary detection of genomic alterations in metastatic castration‑resistant prostate cancer (mCRPC) from CheckMate 9KD through analyses of tumor tissue and plasma DNA.
First Author: Mark Sausen